Astrazeneca PLC (AZN)
AstraZeneca is a pharmaceutical company that develops and sells prescription medicines for cancer, heart, lung and other diseases. It last closed at $182.24 on Nov 17, down 1.00% on the day. AZN reports earnings on Tue, Feb 9, 2027. Over the past 90 days StreetAlpha recorded 5 whale options trades in AZN, 40% of them bullish and 60% bearish. In the past 30 days there were 5 dark pool prints totaling $2.9M, the largest $610K.
Key Stats
Last 12 monthsNot reported for this period.
From AZN's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 24). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 1 analyst who set a price target on AZN in the past 90 days. The average target is $198.00, with a high of $198.00 and a low of $198.00, compared with the last close of $182.24.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 24 | CICC | Initiated | Buy | $198 |
Technical Analysis
The stock is 1% above its 20 day and 7% above its 50 day average. It is 1% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 57). The nearest support is the swing low (Nov 6) at $181.20, and the nearest resistance the Pivot at $182.33.
| RSI (14) | 57.36 | Middle of its range | Neutral |
| MACD | 4.80 | Below its signal line | Bearish |
| Stochastic | 59.8 | Middle of its range | Neutral |
| ADX (14) | 25.1 | Trending up | |
| Williams %R | -52.6 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 15.8 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −0.9% | Change over 10 sessions | Bearish |
| ATR (14) | $4.07 | Typical daily range, 2.2% of price |
| RSI (14) | 55.90 | Middle of its range | Neutral |
| MACD | 0.65 | Above its signal line | Bullish |
| Stochastic | 78.7 | Middle of its range | Neutral |
| ADX (14) | 16.1 | No clear trend | |
| Williams %R | -26.9 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 131.2 | Oversold below −100, overbought above 100 | Overbought |
| Rate of change | +13.8% | Change over 10 sessions | Bullish |
| ATR (14) | $10.15 | Typical daily range, 5.6% of price |
What happened before
See how AZN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How AZN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in AZN in the last 90 days.
Dark Pool
30DAZN Institutional Ownership
Full report →- ●676 buying vs 694 selling
- ▼Shares held by funds -4.7%
- ▼Funds holding -69
- ▲Superinvestors: 5 added, 0 cut
- ▲Put/call 4.27 to 0.43
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 1,447 | 1,516 | −4.6% |
| In funds' top 10 | 47 | 58 | −19.0% |
| Held by funds | – | – | – |
| New / increased | 138 / 538 | 272 / 514 | −14.0% |
| Reduced / sold out | 513 / 181 | 472 / 147 | +12.1% |
| Put/call ratio | 0.43 | 4.27 | −89.8% |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AZN is in one of them and how their past AZN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered AZN in an article yet. Here's the latest on the wider market.
AZN Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Alan ArmstrongHouse | Buy | $1K – $15K | Mar 31, 2026 | Jul 21, 2026 | 112 d |
| Alan ArmstrongHouse | Buy | $15K – $50K | Mar 30, 2026 | Jul 21, 2026 | 113 d |
| Julia LetlowR · LA | Buy | $1K – $15K | Dec 8, 2025 | Jan 13, 2026 | 36 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Dec 18, 2025 | Jan 12, 2026 | 25 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Nov 19, 2025 | Dec 15, 2025 | 26 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Astrazeneca
AstraZeneca is a pharmaceutical company based in Cambridge that researches, develops and sells prescription medicines. Its work covers several therapy areas, including cancer, heart, kidney and metabolic disease, respiratory and immune conditions, rare diseases, and vaccines. Much of its research focuses on new treatments still in clinical trials, which it develops alone or with partners. Its medicines are aimed at patients and the healthcare providers who treat them.
- Headquarters
- Cambridge
- Founded
- 1913
- Website
- astrazeneca.com ↗










